Kanglaite injection combined with hepatic arterial intervention for unresectable hepatocellular carcinoma: A meta-analysis

Journal of Cancer Research and Therapeutics

Volumn 10, Issue 5, 2014, Pages C38-C41

  Fu, Fei ^a   Wan, Yeda ^a   Mulati, ^b   Wu, Tao ^c  

^a TIANJIN HOSPITAL   (China)

^b SHIHEZI UNIVERSITY   (China)

^c HENAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Kanglaite injection; Meta analysis

Indexed keywords

HERBACEOUS AGENT; KANGLAITE; UNCLASSIFIED DRUG; KANG-LAI-TE;

ANALGESIA; ARTICLE; DRUG EFFICACY; EFFECT SIZE; HUMAN; INOPERABLE CANCER; KARNOFSKY PERFORMANCE STATUS; LIVER CELL CARCINOMA; META ANALYSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION; HEPATIC ARTERY; LIVER; LIVER NEOPLASMS; MEDLINE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; VASCULARIZATION;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DRUGS, CHINESE HERBAL; HEPATIC ARTERY; HUMANS; LIVER; LIVER NEOPLASMS; PUBMED; QUALITY OF LIFE;

EID: 84907045532     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.139753     Document Type: Article

References (15)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers CD, Parkin D. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer; Year. Available from: http://globocan.iarc.fr. 2010 [Last accessed on 2010 Aug 17].
3. Wang HL, Chen Y. The clincial efficacy of Kanglaite injection in the treatment of primary liver cancer. J Qilu Tumour 1999;6:159.
4. Ye XZ, Song BY, Liu JH. Kanglaite injection combined with hepatic arterial intervention in the treatment of advanced hepatocellular carcinoma. Chin J Clin Med 2003;4:23-5.
5. Hu JB, Liu SL, Zhou HL. Kanglaite injection combined with hepatic arterial intervention chemotherapy in the treatment of advanced lover cancer. Shanxi Oncol Med 2003;11:48-9.
6. Lv DZ. Kanglaite injection combined with hepatic arterial intervention assistant treatment of liver cancer. N Chin Med 2004;35:415-6.
7. Zhu XF. The clinical observation of the effect of Kanglaite injection combined with chemoembolization primary on middle and advanced stage liver cancer. J Basic Clin Oncol 2006;19:132-4.
8. Lu HZ, Xu XD. Effects of transcatheter arterial chemoenbolization combined with Kanglaite injection on patients with advanced unrespectable hepatocellular carcinoma. Cent Plains Med J 2006;133:3-4.
9. Liang SM, Song J. Kanglaite combined with transcatheter arterial chemoenbolization in the advanced premier liver cancer. Chinese Journal of Modern Applied Pharmacy 2006;23:825-6.
10. Jiang YB. The efficacy of Kanglaite injection in the treatment of primary liver cancer. J Mod Oncol 2006;14:485-6.
11. Yin RR. Hepatic arterial intervention combined with Kanglaite injection in the treatment of primary liver cancer. China Foreign Med Treat 2009;28:78.
12. Chen JG, Zhang SW. Liver cancer epidemic in China: Past, present and future. Semin Cancer Biol 2011;21:59-69.
13. Chen JG, Chen WQ, Zhang SW, Zheng RS, Zhu J, Zhang YH. Incidence and mortality of liver cancer in China: An analysis on data from the National Registration System between 2003 and 2007. Zhonghua Liu Xing Bing Xue Za Zhi 2012;33:547-53.
14. The Editorial Committee. Atlas of cancer mortality in the People's Republic of China. Shanghai: China Map Press; 1979. p. 1-99.
15. Zhan YP, Huang XE, Cao J, Lu YY, Wu XY, Liu J, et al. Clinical safety and efficacy of Kanglaite® (Coix Seed Oil) injection combined with chemotherapy in treating patients with gastric cancer. Asian Pac J Cancer Prev 2012;13:5319-21.